Valuation Picture: Premium Reflecting Sector Leadership
The current P/E of 63.63 for Apollo Hospitals Enterprise Ltd. sits slightly above the hospital industry average of 62.71, indicating a valuation premium of approximately 1.5%. This premium suggests that investors are willing to pay a higher multiple for the company’s earnings relative to its peers, potentially reflecting its market leadership and consistent earnings growth. However, the premium is not excessive, signalling a valuation that remains broadly in line with sector norms. Apollo Hospitals’s market capitalisation of ₹1,14,700.62 crores places it firmly in the large-cap category, reinforcing its stature within the hospital sector.
Performance Across Timeframes: Strong Long-Term Gains with Recent Stability
Examining returns over multiple periods reveals a compelling long-term growth story. Over the past 10 years, Apollo Hospitals has delivered a remarkable 500.18% gain, significantly outperforming the Sensex’s 195.21% rise during the same period. The five-year return of 147.59% and three-year return of 79.59% further underscore sustained outperformance.
In the more recent past, the stock has maintained positive momentum. Year-to-date, it has gained 13.27%, contrasting sharply with the Sensex’s 12.35% decline. The one-month and three-month returns of 4.23% and 4.81% respectively also outpace the Sensex, which fell 4.87% and 9.81% over these intervals. This divergence highlights the stock’s resilience amid broader market weakness — Apollo Hospitals’s ability to buck the trend raises the question: is this a sign of underlying strength or a temporary anomaly?
Short-Term Fluctuations and Daily Performance
Despite the positive medium- and long-term trends, the stock’s short-term performance shows some softness. The one-day change was a decline of 0.61%, slightly underperforming the sector by 0.39%. Over the past week, the stock dipped 0.30%, while the Sensex gained 0.11%. This recent weakness may reflect profit-taking or sector-specific factors, but the stock remains close to its 52-week high, just 3.83% below the peak of ₹8,249.95. Could this proximity to the high mark signal a consolidation phase before the next move?
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Moving Average Configuration: Mixed Signals from Technicals
The technical picture for Apollo Hospitals is nuanced. The stock is trading above its 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally positive medium- to long-term trend. However, it remains below its 5-day moving average, suggesting some short-term hesitation or profit booking. This configuration often points to a recent pullback within an overall uptrend, raising the question of whether the current dip is a pause before further gains or a sign of a more sustained correction. Is this a genuine recovery or a dead-cat bounce?
Sector Performance Context: Hospital Industry Trends
The hospital sector has experienced mixed results recently, with some companies reporting positive earnings surprises while others face margin pressures. Within this environment, Apollo Hospitals stands out for its relative stability and consistent growth. The sector’s average P/E of 62.71 reflects moderate valuation levels, and Apollo Hospitals’ premium is in line with its leadership position. The sector’s mixed performance underscores the importance of analysing individual company data rather than relying solely on broader industry trends.
Rating Reassessment: Previously Hold, Now Updated
MarketsMOJO previously rated Apollo Hospitals Enterprise Ltd. as Hold. The rating was reassessed on 11 May 2026, reflecting updated analysis of the company’s financials, valuation, and technical indicators. While the current rating is not disclosed, the reassessment signals a shift in the evaluation framework. The stock’s strong long-term returns and valuation premium are balanced by recent short-term softness and technical caution — should investors in Apollo Hospitals hold, buy more, or reconsider?
Thinking about Apollo Hospitals Enterprise Ltd.? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this large-cap stock!
- - Real-time Verdict available
- - Financial health breakdown
- - Fair valuation calculated
Conclusion: A Balanced View from Data
The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a slight valuation premium to its sector, supported by strong long-term performance and resilience in recent months. The mixed signals from short-term price action and moving averages suggest a phase of consolidation or mild correction within an overall positive trend. The reassessment of the rating from Hold reflects these complexities, emphasising the need for investors to weigh both valuation and technical factors carefully. What is the current rating for Apollo Hospitals, and how should investors interpret this data-driven update?
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
